Medera has published a study demonstrating the use of machine learning to improve drug screening with human mini-heart technology, showcasing the potential for AI to revolutionize the heart disease industry. By utilizing advanced AI techniques such as deep learning and neural networks, companies like Medera can optimize drug development processes and improve outcomes for heart disease patients through innovative products and personalized treatments.
Read more
NEC X has invested in Gpx to advance AI-driven chronic disease monitoring, specifically focusing on heart disease. Gpx's technology utilizes Natural Language Processing (NLP) and Machine Learning to provide personalized insights for heart disease patients, improving outcomes and reducing healthcare costs.
Read more
Eko Health has received a Category III CPT code for their Sensora AI platform, which uses Artificial Intelligence to detect heart disease. This platform utilizes Machine Learning and Neural Networks to analyze heart sounds and provide accurate diagnoses, offering a significant advancement in the heart disease industry for both companies and consumers.
Read moreAnumana will showcase AI-driven cardiovascular solutions at AHA and NAPCRG 2024, using advanced technologies such as Machine Learning and Neural Networks to improve heart disease detection and treatment for consumers. This will have a significant impact on the heart disease industry, benefiting companies like Anumana and consumers seeking effective products and services in managing heart conditions.
Read more
Cardiosense presented interim clinical study data for their machine learning algorithm designed to aid in heart failure management at the Transcatheter Cardiovascular Therapeutics (TCT) 2024 Scientific Symposium. The algorithm, utilizing artificial intelligence and deep learning, aims to improve patient outcomes and reduce hospital readmissions by providing real-time monitoring and analysis of heart health data.
Read moreAn AI algorithm called DeepHEART has been developed to accurately diagnose heart disease using electrocardiogram (ECG) data, with a success rate of 90%. This technology has the potential to revolutionize the heart disease industry and benefit companies like Philips Healthcare or Siemens Healthineers, ultimately improving outcomes for heart disease patients such as those using medical devices like Abbott's cardiac monitoring systems.
Read more
The article discusses how a study called CONFIRM2 demonstrated the effectiveness of using Artificial Intelligence in quantifying coronary artery disease events by analyzing plaque features. By utilizing Machine Learning algorithms, researchers were able to predict cardiovascular events in patients more accurately, leading to potential advancements in the diagnosis and treatment of heart disease. An example mentioned in the article is the use of Deep Learning techniques to analyze images from coronary computed tomography angiography (CCTA) scans, which could provide valuable insights for companies like HeartFlow and HeartFlow Analysis.
Read moreArtificial Intelligence models such as GTEX and CVext can effectively stratify the risk of coronary artery disease in patients based on PET/CT imaging data, offering a more accurate and efficient diagnostic approach in the healthcare industry. Companies like HeartFlow are developing AI-powered solutions like the HeartFlow Analysis to aid in the assessment and diagnosis of heart disease, ultimately benefiting consumers by providing personalized and timely care.
Read more
Artificial intelligence and machine learning technologies are revolutionizing the way first responders in the Heart Disease industry operate, with companies like HeartFlow utilizing deep learning algorithms to improve the accuracy of diagnosing and treating heart disease. These technologies are enhancing the efficiency and effectiveness of emergency response teams, allowing for quicker intervention and potentially saving more lives in a time-critical industry.
Read more
Texas-based tech companies like PCCI and HeartTest are using artificial intelligence and machine learning to revolutionize the heart disease industry by developing innovative products for early detection and personalized care. Through advancements in natural language processing, computer vision, and neural networks, these companies are improving outcomes for heart disease patients and transforming the way healthcare providers diagnose and treat cardiovascular conditions.
Read more
Artificial intelligence and machine learning technologies such as Generative AI, LLMs, and GPT are being used in the healthcare industry to improve remote patient monitoring for conditions like heart disease. Companies like Biofourmis and Current Health are leveraging these technologies to provide more personalized and efficient care to patients through advanced analytics and predictive algorithms.
Read more
Boston is at the forefront of personalized medicine, with companies like VeriSIM Life using AI and machine learning to create virtual patients and simulate drug responses. Other companies like HeartFlow are using deep learning and computer vision to improve the diagnosis and treatment of heart disease by analyzing detailed blood flow data and identifying blockages in arteries. This revolutionary approach is transforming the traditional healthcare industry and providing more accurate and personalized treatment options for patients with heart disease.
Read moreArtificial Intelligence and Big Data analytics are revolutionizing the heart disease industry, with companies like Cardiogram using machine learning algorithms to predict heart conditions in patients through wearable devices. This technology is enabling better diagnosis, treatment, and prevention of heart disease, ultimately improving outcomes for consumers and reducing healthcare costs.
Read moreHeartFlow, a leader in AI-powered heart disease diagnosis, recently received a decision from CMS approving reimbursement for coronary computed tomography angiography (CCTA) with their HeartFlow Analysis software, providing improved access for patients. This decision showcases the growing influence of AI and machine learning technologies in the healthcare industry, specifically within the cardiovascular sector, as companies like HeartFlow are utilizing these advancements to enhance diagnostic accuracy and patient outcomes.
Read more
Vietnam has approved a Korean predictive AI technology for early detection of sepsis in hospitals, showing the potential of AI in improving outcomes for patients with infections like sepsis. This AI technology, developed by Vuno Inc., uses deep learning algorithms to analyze medical data and predict when a patient is at risk for sepsis, demonstrating the growing impact of AI and machine learning in the healthcare industry.
Read more
An Australian university has teamed up with Apollo Hospitals to improve digital health research with a special focus on heart diseases, using artificial intelligence, machine learning, and natural language processing to analyze data. This partnership aims to develop personalized treatment plans for cardiac patients using innovative predictive tools like Myron AI, enhancing outcomes for individuals with heart disease.
Read more
The FDA has cleared an AI tool called Subtle Medical's SubtleChest that flags signs of heart disease on chest CT scans. This AI tool aims to assist healthcare providers in detecting heart disease earlier and more accurately, potentially benefiting companies like Bayer and GE Healthcare as well as improving outcomes for heart disease patients.
Read more
A new Category I CPT code has been issued for AI-enabled coronary plaque analysis software, such as Subtle Medical's SubtlePET technology. This development highlights the increasing integration of Artificial Intelligence in the cardiovascular industry to provide more accurate and efficient diagnosis and treatment of heart diseases.
Read moreArtificial Intelligence technologies such as deep learning and neural networks are being used in the healthcare industry to improve the diagnosis and treatment of heart disease. For example, companies like AliveCor are developing smartphone apps that use AI to help diagnose conditions like ST-elevation myocardial infarction (STEMI) more accurately and quickly than medical experts, potentially revolutionizing the way heart disease is managed and treated.
Read moreKing Faisal Specialist Hospital & Research Centre (KFSHRC) is at the forefront of using Artificial Intelligence (AI) for diagnostics and minimally invasive surgeries in the treatment of heart disease. By leveraging Machine Learning algorithms, KFSHRC has implemented AI-powered solutions such as Generative Pre-trained Transformers (GPT) and Natural Language Processing (NLP) to improve patient outcomes and revolutionize the way heart disease is diagnosed and treated within the healthcare industry.
Read morePhilips showcased AI-driven cardiology innovations at TCT 2024, such as the IntelliSpace Cardiovascular platform which uses Machine Learning to improve patient care by providing comprehensive analysis of heart disease conditions. Companies like Siemens Healthineers and GE Healthcare are also incorporating Deep Learning and Computer Vision technologies into their cardiac imaging solutions to enhance accuracy and efficiency for heart disease diagnosis and treatment.
Read more
Anumana and the Accelerating Medicines Partnership Heart Failure Program are collaborating on ECG AI™ technology to enhance early detection of heart diseases using Artificial Intelligence. This partnership aims to bring groundbreaking solutions to the heart disease industry, benefiting companies like Eko and product consumers with innovative tools for improved cardiovascular care.
Read moreHeartFlow has received a new Category I CPT code from the American Medical Association for their AI-enabled plaque analysis product, demonstrating the increasing integration of AI in the heart disease industry. This development showcases how companies like HeartFlow are leading the way in utilizing advanced technologies to provide more efficient and accurate diagnosis for coronary artery disease risk assessment.
Read moreAI technology, such as Caption AI and EchoGo Core, has been developed by companies like Caption Health and Ultromics to accurately predict patients at high risk of major adverse cardiac events, ultimately improving patient outcomes in the heart disease industry. Through the utilization of Machine Learning, Deep Learning, and Natural Language Processing (NLP), these tools assist healthcare professionals in diagnosing heart conditions more effectively.
Read more
Boston Scientific's HeartLogic technology, powered by AI, is improving outcomes for congestive heart failure patients through remote monitoring. By analyzing data collected from implanted devices, healthcare providers can offer personalized and proactive care, leading to reduced hospitalizations.
Read moreWould you like us to add an industry? Let us know
Would you like us to add a health topic? Let us know
Would you like us to add a profession? Let us know
Would you like us to add a location? Let us know
Create AI solutions up to 17x faster with our low-code development platform
Supercharge your workplace with a secure, private, local AI management application tailored to deliver enhanced business solutions.
Synchronize your workforce with an AI-driven management system that optimizes task delegation, and communication to empower frontline teams and boost productivity.
